Cytokinetics Inc (CYTK)

Stock-Based Compensation

$35.71M

Quarterly · Period ending: · USD

CYTK logo

CYTK Stock-Based Compensation

Latest reported$35.71M
CYTK Quarterly Stock-Based Comp ($389.00K → $35.71M)
High-resolution chart · PNG

CYTK stock-based compensation history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Cytokinetics Inc Stock-Based Compensation — Quarterly (USD)
Period endingStock-Based Compensation (USD)
35,711,000
30,394,000
0
30,696,000
27,535,000
23,549,000
26,250,000
25,356,000
24,622,000
21,612,000
19,487,000
18,716,000
18,668,000
0
13,498,000
0
12,195,000
8,985,000
6,711,000
7,767,000
7,093,000
5,261,000
4,877,000
4,692,000
4,527,000
3,524,000
0
2,783,000
2,819,000
2,282,000
9,761,000
2,572,000
2,505,000
2,403,000
2,440,000
2,447,000
2,219,000
1,922,000
1,880,000
1,866,000
1,789,000
1,611,000
1,348,000
1,121,000
1,202,000
896,000
886,000
891,000
859,000
694,000
656,000
845,000
1,130,000
966,000
907,000
1,064,000
869,000
943,000
841,000
736,000
731,000
761,000
852,000
1,159,000
1,012,000
994,000
1,172,000
1,261,000
1,224,000
1,249,000
5,606,000
0
0
1,160,000
5,553,000
0
0
1,160,000
4,643,000
0
0
938,000
1,427,000
0
0
402,000
926,000
0
0
389,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.